Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Gregory Schwartz

Concepts (478)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Acute Coronary Syndrome
69
2024
254
17.030
 Why?
Anticholesteremic Agents
45
2023
128
12.630
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
52
2023
372
8.280
 Why?
Antibodies, Monoclonal, Humanized
35
2023
665
6.180
 Why?
Myocardial Infarction
42
2023
930
5.570
 Why?
Cholesterol, LDL
44
2023
307
5.120
 Why?
Lipoprotein(a)
15
2023
51
4.760
 Why?
Cardiovascular Diseases
32
2023
1729
3.850
 Why?
Proprotein Convertase 9
22
2023
61
3.560
 Why?
Coronary Disease
14
2020
347
3.250
 Why?
Angina, Unstable
18
2019
72
3.020
 Why?
Cholesterol, HDL
13
2020
184
2.880
 Why?
Sulfhydryl Compounds
10
2020
177
2.740
 Why?
Hypercholesterolemia
11
2023
90
2.700
 Why?
Diabetes Mellitus, Type 2
21
2024
2098
2.640
 Why?
Heptanoic Acids
20
2016
60
2.600
 Why?
Stroke
29
2023
1015
2.540
 Why?
Pyrroles
20
2016
181
2.420
 Why?
Quinazolinones
7
2021
19
2.340
 Why?
Dyslipidemias
6
2023
154
2.280
 Why?
Serine Proteinase Inhibitors
3
2020
35
1.790
 Why?
Myocardial Ischemia
16
2018
236
1.770
 Why?
Secondary Prevention
10
2019
222
1.710
 Why?
Thiazolidinediones
10
2017
143
1.690
 Why?
Cholesterol
10
2022
368
1.690
 Why?
Double-Blind Method
38
2023
1664
1.590
 Why?
Atherosclerosis
10
2022
342
1.580
 Why?
Hypoglycemic Agents
17
2022
1006
1.560
 Why?
Esters
9
2020
61
1.510
 Why?
Amides
9
2020
88
1.490
 Why?
Oxazoles
8
2019
29
1.480
 Why?
Cholesterol Ester Transfer Proteins
5
2016
17
1.430
 Why?
Treatment Outcome
56
2023
9122
1.420
 Why?
Thiophenes
8
2019
108
1.390
 Why?
Coronary Artery Disease
6
2023
608
1.260
 Why?
Aged
65
2024
19119
1.260
 Why?
Ventricular Fibrillation
3
2017
51
1.250
 Why?
Risk Factors
39
2024
8642
1.250
 Why?
Myocardial Contraction
12
2013
313
1.240
 Why?
Insulin Resistance
10
2018
1077
1.220
 Why?
C-Reactive Protein
11
2022
363
1.210
 Why?
Antibodies, Monoclonal
7
2023
1268
1.210
 Why?
Swine
33
2017
704
1.190
 Why?
Humans
140
2024
115039
1.160
 Why?
Metabolic Syndrome
4
2013
324
1.140
 Why?
Middle Aged
67
2024
26827
1.130
 Why?
Diabetic Angiopathies
2
2019
244
1.110
 Why?
Myocardium
21
2004
922
1.100
 Why?
Risk Assessment
18
2024
2976
1.100
 Why?
Myocardial Reperfusion Injury
5
2013
91
1.050
 Why?
Ischemic Attack, Transient
6
2018
61
1.000
 Why?
Male
84
2023
55730
1.000
 Why?
Lipoproteins, HDL
4
2019
76
0.970
 Why?
Heart
9
2009
610
0.970
 Why?
Female
98
2022
59611
0.960
 Why?
Peripheral Arterial Disease
3
2020
380
0.960
 Why?
Proteins
3
2020
915
0.960
 Why?
PPAR gamma
6
2022
184
0.940
 Why?
Proprotein Convertases
2
2014
14
0.910
 Why?
Insulin
7
2021
2082
0.820
 Why?
Fatty Acids, Nonesterified
4
2018
151
0.780
 Why?
Hospitalization
5
2019
1754
0.770
 Why?
Patient Admission
2
2021
175
0.770
 Why?
Coronary Circulation
18
2004
135
0.740
 Why?
Cardiovascular Agents
4
2021
125
0.730
 Why?
Molecular Targeted Therapy
2
2014
347
0.730
 Why?
Recurrence
11
2021
941
0.700
 Why?
Energy Metabolism
13
2004
729
0.690
 Why?
Triglycerides
4
2015
471
0.670
 Why?
Randomized Controlled Trials as Topic
16
2023
1214
0.660
 Why?
Adiponectin
2
2018
212
0.630
 Why?
Lipid Metabolism
2
2014
449
0.630
 Why?
Swine, Miniature
3
2013
71
0.620
 Why?
Venous Thrombosis
1
2020
144
0.620
 Why?
Heart Arrest
4
2017
289
0.610
 Why?
Brain Ischemia
5
2022
297
0.600
 Why?
Time Factors
18
2021
6141
0.600
 Why?
Ezetimibe
4
2023
24
0.590
 Why?
Aldosterone
1
2017
42
0.560
 Why?
Biomarkers
17
2024
3419
0.560
 Why?
Rosuvastatin Calcium
4
2022
17
0.550
 Why?
Venous Thromboembolism
1
2020
231
0.550
 Why?
Cardiovascular System
1
2018
126
0.550
 Why?
RNA, Small Interfering
6
2023
541
0.530
 Why?
Patient Readmission
2
2021
606
0.500
 Why?
Arteriosclerosis
2
2014
82
0.490
 Why?
Drug Therapy, Combination
6
2020
955
0.470
 Why?
Adenosine Triphosphate
11
2017
431
0.460
 Why?
Metformin
1
2017
278
0.450
 Why?
Veterans
3
2023
1238
0.440
 Why?
Diabetes Complications
3
2021
212
0.440
 Why?
Atrial Fibrillation
2
2022
325
0.440
 Why?
Animals
43
2017
31867
0.430
 Why?
Heart Failure
9
2022
1962
0.420
 Why?
Blood Pressure
11
2012
1539
0.420
 Why?
Hemodynamics
11
2007
1017
0.420
 Why?
Magnetic Resonance Spectroscopy
14
2019
482
0.410
 Why?
Ventricular Function, Left
9
2004
469
0.410
 Why?
Phosphocreatine
10
1995
36
0.410
 Why?
Proportional Hazards Models
8
2019
1080
0.400
 Why?
Uncertainty
1
2012
95
0.390
 Why?
Dietary Fats
2
2013
290
0.390
 Why?
Coronary Vessels
7
2012
230
0.380
 Why?
Follow-Up Studies
10
2023
4420
0.380
 Why?
Glucose
5
2020
900
0.370
 Why?
Drug Administration Schedule
8
2019
719
0.370
 Why?
Reperfusion Injury
2
2005
254
0.360
 Why?
Systole
7
2001
171
0.360
 Why?
Fluorobenzenes
2
2014
11
0.360
 Why?
Research Design
3
2009
930
0.360
 Why?
Renal Insufficiency, Chronic
3
2021
486
0.340
 Why?
Phospholipases A2, Secretory
4
2014
23
0.340
 Why?
Risk
8
2018
815
0.330
 Why?
Diastole
5
2001
131
0.330
 Why?
Ischemia
1
2012
363
0.320
 Why?
Obesity
2
2013
2524
0.320
 Why?
Ventricular Dysfunction, Right
3
2007
218
0.320
 Why?
Cohort Studies
6
2023
4904
0.320
 Why?
Surgical Procedures, Operative
4
2017
207
0.310
 Why?
KATP Channels
1
2008
16
0.300
 Why?
Apolipoproteins B
5
2022
41
0.300
 Why?
Mortality
3
2017
287
0.300
 Why?
Chromans
3
2004
21
0.290
 Why?
Dose-Response Relationship, Drug
7
2019
1857
0.290
 Why?
Survival Analysis
7
2018
1211
0.290
 Why?
Hypolipidemic Agents
3
2022
87
0.290
 Why?
Prognosis
6
2024
3334
0.290
 Why?
Pyrimidines
2
2014
375
0.290
 Why?
Veterans Health
2
2020
165
0.280
 Why?
Sulfonamides
2
2014
445
0.280
 Why?
Phospholipids
3
2018
199
0.270
 Why?
Incidence
5
2022
2318
0.260
 Why?
Subtilisins
2
2023
9
0.260
 Why?
Disease Models, Animal
7
2013
3545
0.260
 Why?
Fenofibrate
1
2005
24
0.260
 Why?
Oxygen Consumption
8
2000
588
0.250
 Why?
Acute Disease
7
2012
915
0.250
 Why?
Apolipoprotein A-I
2
2018
25
0.240
 Why?
Acetates
3
2019
95
0.240
 Why?
Prediabetic State
2
2020
224
0.240
 Why?
Natriuretic Peptide, Brain
3
2024
96
0.240
 Why?
Clinical Trials, Phase III as Topic
2
2023
82
0.240
 Why?
Adrenergic beta-Antagonists
3
2013
294
0.240
 Why?
Cardiotonic Agents
3
2005
119
0.240
 Why?
Morbidity
5
2017
279
0.230
 Why?
Blood Glucose
5
2020
1821
0.230
 Why?
Cause of Death
5
2017
364
0.230
 Why?
Hyperemia
3
1991
45
0.230
 Why?
Syndrome
6
2007
337
0.230
 Why?
Dobutamine
4
2000
33
0.220
 Why?
Thiazoles
2
2003
110
0.220
 Why?
Phosphorylation
3
2013
1572
0.220
 Why?
Serine Endopeptidases
2
2014
102
0.220
 Why?
Indoles
3
2019
304
0.220
 Why?
Isoproterenol
3
1998
109
0.210
 Why?
Peroxisome Proliferator-Activated Receptors
4
2017
15
0.210
 Why?
Predictive Value of Tests
5
2017
1812
0.200
 Why?
Propensity Score
2
2021
224
0.200
 Why?
Insulin Receptor Substrate Proteins
2
2013
56
0.190
 Why?
Receptors, Cytoplasmic and Nuclear
1
2003
193
0.190
 Why?
PPAR alpha
4
2022
52
0.190
 Why?
Diacetyl
1
2001
7
0.190
 Why?
Cost-Benefit Analysis
2
2020
544
0.190
 Why?
Peptide Fragments
3
2024
668
0.190
 Why?
Cytokines
2
2005
1843
0.190
 Why?
Muscles
1
2022
324
0.190
 Why?
Hyperlipoproteinemia Type II
1
2021
26
0.180
 Why?
Mental Status and Dementia Tests
1
2021
21
0.180
 Why?
Coronary Artery Bypass
2
2019
196
0.180
 Why?
Perioperative Care
2
2017
125
0.180
 Why?
Cataract
1
2023
185
0.180
 Why?
Apolipoproteins
3
2012
36
0.180
 Why?
Myocardial Reperfusion
1
2000
49
0.180
 Why?
Phosphates
5
1992
159
0.180
 Why?
Glucagon-Like Peptide-1 Receptor
1
2020
71
0.170
 Why?
Calpain
2
2012
53
0.170
 Why?
Lipoproteins, LDL
2
2014
129
0.170
 Why?
Cadmium
1
2000
58
0.170
 Why?
Sodium
1
2020
183
0.170
 Why?
Matrix Metalloproteinases
1
2000
89
0.170
 Why?
Oncogenes
1
2000
104
0.170
 Why?
Potassium
1
2000
128
0.170
 Why?
Non-alcoholic Fatty Liver Disease
1
2022
246
0.170
 Why?
Proto-Oncogene Proteins c-akt
2
2013
400
0.160
 Why?
United States
6
2023
12224
0.160
 Why?
Injections, Subcutaneous
1
2019
133
0.160
 Why?
Renin-Angiotensin System
1
2019
71
0.160
 Why?
Alkaline Phosphatase
1
2019
143
0.160
 Why?
Multifactorial Inheritance
1
2019
125
0.160
 Why?
Adenylyl Cyclases
2
2016
84
0.150
 Why?
Early Termination of Clinical Trials
2
2015
14
0.150
 Why?
Immunoturbidimetry
1
2018
1
0.150
 Why?
Risk Reduction Behavior
1
2020
201
0.150
 Why?
Carotid Artery Diseases
1
2018
57
0.150
 Why?
Collagen
1
2000
416
0.150
 Why?
American Heart Association
1
2019
264
0.150
 Why?
Adrenergic beta-Agonists
1
1998
128
0.150
 Why?
Postoperative Complications
2
2019
2150
0.150
 Why?
Global Health
2
2017
288
0.140
 Why?
Hypertension, Pulmonary
3
2012
1736
0.140
 Why?
Citrate (si)-Synthase
1
2017
46
0.140
 Why?
Pharmacogenetics
2
2016
149
0.140
 Why?
Inflammation
6
2016
2485
0.140
 Why?
Percutaneous Coronary Intervention
2
2019
445
0.140
 Why?
Signal Transduction
1
2009
4525
0.140
 Why?
Australia
4
2019
206
0.140
 Why?
Administration, Intravenous
1
2017
125
0.140
 Why?
Epigenesis, Genetic
1
2021
524
0.140
 Why?
Drug Design
1
2017
151
0.140
 Why?
Clinical Trials as Topic
2
2018
937
0.140
 Why?
Lipoproteins
2
2014
160
0.130
 Why?
Inflammation Mediators
2
2013
476
0.130
 Why?
AMP-Activated Protein Kinases
1
2017
175
0.130
 Why?
Diet
2
2013
1076
0.130
 Why?
Anti-Arrhythmia Agents
2
2012
106
0.130
 Why?
Platelet Aggregation Inhibitors
1
2019
399
0.130
 Why?
Heart Ventricles
6
2012
714
0.130
 Why?
Vasodilation
2
2013
417
0.130
 Why?
Hospital Mortality
1
2019
776
0.130
 Why?
Transcription Factors
1
2003
1531
0.120
 Why?
ATP Binding Cassette Transporter 1
1
2015
10
0.120
 Why?
Recombinant Proteins
1
2018
1237
0.120
 Why?
Chromosomes, Human, Pair 16
1
2015
30
0.120
 Why?
Disease Progression
4
2018
2389
0.120
 Why?
Environment
1
2016
335
0.120
 Why?
Simvastatin
1
2015
59
0.120
 Why?
Homeostasis
1
2018
578
0.120
 Why?
Stents
1
2018
476
0.120
 Why?
Residence Characteristics
1
2016
275
0.120
 Why?
Endovascular Procedures
1
2018
268
0.120
 Why?
Heart Rate
5
2001
705
0.120
 Why?
Linkage Disequilibrium
1
2015
245
0.120
 Why?
Aged, 80 and over
7
2020
6357
0.120
 Why?
Serum Amyloid A Protein
3
2013
29
0.120
 Why?
Fasting
1
2015
242
0.110
 Why?
Retrospective Studies
6
2018
12547
0.110
 Why?
Phospholipases A
1
2014
101
0.110
 Why?
Mendelian Randomization Analysis
1
2013
43
0.110
 Why?
Ventricular Function, Right
1
1995
252
0.110
 Why?
Acyl Coenzyme A
1
2013
30
0.110
 Why?
Pancreatic Neoplasms
1
2000
722
0.110
 Why?
Heart Function Tests
1
2013
59
0.110
 Why?
Case-Control Studies
1
2019
3015
0.100
 Why?
Hydroxy Acids
1
2012
3
0.100
 Why?
Decanoic Acids
1
2012
7
0.100
 Why?
Prospective Studies
2
2021
6232
0.100
 Why?
Ischemic Preconditioning, Myocardial
1
2012
29
0.100
 Why?
Talin
1
2012
7
0.100
 Why?
Cardiolipins
1
2013
71
0.100
 Why?
Potassium Channel Blockers
1
2012
29
0.100
 Why?
Nitric Oxide Synthase Type III
1
2013
184
0.100
 Why?
Glyburide
1
2012
35
0.100
 Why?
Europe
3
2019
336
0.100
 Why?
North America
3
2019
259
0.100
 Why?
Hypertension
1
2000
1058
0.100
 Why?
1-Alkyl-2-acetylglycerophosphocholine Esterase
1
2012
21
0.100
 Why?
Practice Guidelines as Topic
1
2019
1398
0.100
 Why?
Polymorphism, Genetic
1
2015
617
0.100
 Why?
DNA
2
2013
1352
0.100
 Why?
Keto Acids
3
2019
12
0.100
 Why?
Arteries
1
2013
249
0.090
 Why?
MAP Kinase Signaling System
1
2013
276
0.090
 Why?
Death, Sudden, Cardiac
1
2012
160
0.090
 Why?
Tissue Plasminogen Activator
2
2013
227
0.090
 Why?
United States Department of Veterans Affairs
3
2016
557
0.090
 Why?
Fractures, Bone
1
2016
373
0.090
 Why?
Myocardial Revascularization
3
2017
67
0.090
 Why?
Adult
8
2020
30655
0.090
 Why?
Gene Expression Regulation
2
2013
2329
0.090
 Why?
RNA, Messenger
3
2015
2563
0.090
 Why?
Neoplasms
1
2023
2106
0.080
 Why?
Macrophages
1
2016
1267
0.080
 Why?
Phosphorus
4
1995
81
0.080
 Why?
MicroRNAs
1
2015
603
0.080
 Why?
Diabetes Mellitus
1
2016
906
0.080
 Why?
Vascular Diseases
2
2022
231
0.080
 Why?
Electrocardiography
1
2011
562
0.080
 Why?
Ventricular Pressure
1
2007
37
0.070
 Why?
Phosphatidylinositol 3-Kinases
1
2009
331
0.070
 Why?
Models, Biological
1
2014
1636
0.070
 Why?
Ultrasonography, Interventional
2
2018
123
0.070
 Why?
Survival Rate
1
2011
1646
0.070
 Why?
Reactive Oxygen Species
1
2009
536
0.070
 Why?
Age Factors
2
2007
2894
0.070
 Why?
Kaplan-Meier Estimate
2
2020
814
0.070
 Why?
Angiomatosis
1
2006
4
0.070
 Why?
Hemangioma, Capillary
1
2006
13
0.070
 Why?
Ultrasonography
1
2009
636
0.070
 Why?
Anti-Inflammatory Agents
1
2009
451
0.070
 Why?
Lactic Acid
2
1998
278
0.070
 Why?
Cerebrovascular Disorders
2
2017
83
0.060
 Why?
Chronic Disease
1
2011
1591
0.060
 Why?
Sus scrofa
1
2004
45
0.060
 Why?
alpha-Tocopherol
1
2004
24
0.060
 Why?
Arterial Occlusive Diseases
2
1982
73
0.060
 Why?
Linear Models
2
2013
776
0.060
 Why?
Antigen-Antibody Complex
1
2004
88
0.060
 Why?
Least-Squares Analysis
1
2004
73
0.060
 Why?
CD40 Ligand
1
2004
42
0.060
 Why?
Multicenter Studies as Topic
2
2012
250
0.060
 Why?
Economics, Pharmaceutical
1
2003
10
0.060
 Why?
Muscular Diseases
1
2004
106
0.060
 Why?
Comorbidity
2
2019
1457
0.060
 Why?
Guidelines as Topic
1
2005
245
0.050
 Why?
Lactates
2
1994
84
0.050
 Why?
Regional Blood Flow
2
1996
428
0.050
 Why?
Death
2
2019
109
0.050
 Why?
Creatine Kinase
1
2022
75
0.050
 Why?
Pharmacogenomic Testing
1
2022
53
0.050
 Why?
Multivariate Analysis
2
2017
1435
0.050
 Why?
Oxidation-Reduction
3
2012
926
0.050
 Why?
Goals
1
2022
152
0.050
 Why?
Verapamil
1
2001
32
0.050
 Why?
Receptors, Immunologic
1
2022
201
0.050
 Why?
Organ Preservation Solutions
1
2001
41
0.050
 Why?
Antioxidants
1
2004
530
0.050
 Why?
Arrhythmias, Cardiac
1
2003
278
0.050
 Why?
Controlled Clinical Trials as Topic
1
2000
27
0.050
 Why?
Liver Cirrhosis
1
2022
235
0.050
 Why?
Ventricular Dysfunction
1
2000
16
0.050
 Why?
Myocardial Stunning
1
2000
5
0.050
 Why?
Collagenases
1
2000
22
0.050
 Why?
Tissue Inhibitor of Metalloproteinases
1
2000
16
0.050
 Why?
Hexamethonium
1
2000
4
0.040
 Why?
Interleukin-6
3
2013
676
0.040
 Why?
Atropine
1
2000
31
0.040
 Why?
Dilatation, Pathologic
1
2000
56
0.040
 Why?
Health Care Costs
1
2003
381
0.040
 Why?
Louisiana
1
2000
24
0.040
 Why?
Dipeptides
2
2012
48
0.040
 Why?
Cell Line
2
2016
2645
0.040
 Why?
Occupations
1
2000
36
0.040
 Why?
Pericardium
1
2000
49
0.040
 Why?
Matrix Metalloproteinase 9
1
2000
119
0.040
 Why?
Antigens, CD
1
2022
441
0.040
 Why?
Blood Chemical Analysis
1
2020
90
0.040
 Why?
Clinical Trials, Phase II as Topic
1
2019
59
0.040
 Why?
Ventricular Dysfunction, Left
1
2003
361
0.040
 Why?
Phospholipase A2 Inhibitors
1
2019
3
0.040
 Why?
Placebo Effect
1
2019
51
0.040
 Why?
Logistic Models
1
2004
1839
0.040
 Why?
New Zealand
1
2019
41
0.040
 Why?
Insulin Antagonists
1
1998
6
0.040
 Why?
Ventricular Function
1
1999
56
0.040
 Why?
Drug Combinations
1
2000
287
0.040
 Why?
Pulmonary Artery
2
2006
1028
0.040
 Why?
India
1
2019
135
0.040
 Why?
Hungary
1
2018
3
0.040
 Why?
Hormone Antagonists
1
1998
33
0.040
 Why?
Somatostatin
1
1998
52
0.040
 Why?
Israel
1
2018
37
0.040
 Why?
Placebos
1
2019
198
0.040
 Why?
Infusion Pumps
1
2018
31
0.040
 Why?
Netherlands
1
2018
65
0.040
 Why?
Microscopy, Electron
1
1999
410
0.040
 Why?
Elasticity
1
1999
190
0.040
 Why?
Protective Factors
1
2018
87
0.040
 Why?
Drug Interactions
1
2019
347
0.040
 Why?
Erythrocytes
1
2022
591
0.040
 Why?
Blood Flow Velocity
1
1999
390
0.040
 Why?
Lipids
1
2001
586
0.040
 Why?
Down-Regulation
1
2019
599
0.040
 Why?
Selection Bias
1
2017
33
0.040
 Why?
Echocardiography, Transesophageal
1
1997
89
0.040
 Why?
Drug Evaluation, Preclinical
1
2017
165
0.030
 Why?
Poverty Areas
1
2016
32
0.030
 Why?
Attitude of Health Personnel
1
2004
976
0.030
 Why?
Catheterization
1
1997
159
0.030
 Why?
Cognitive Dysfunction
1
2021
273
0.030
 Why?
Urban Health
1
2016
73
0.030
 Why?
Rural Health
1
2016
67
0.030
 Why?
Chi-Square Distribution
1
2017
498
0.030
 Why?
Drug Discovery
1
2017
124
0.030
 Why?
Cardiac Catheterization
1
2000
535
0.030
 Why?
Pharmacogenomic Variants
1
2016
33
0.030
 Why?
Internationality
1
2017
144
0.030
 Why?
Drug Industry
1
2017
104
0.030
 Why?
Albuminuria
1
2017
164
0.030
 Why?
Membrane Proteins
1
2022
1019
0.030
 Why?
Fatty Acids
1
1998
385
0.030
 Why?
Genome-Wide Association Study
1
2022
1203
0.030
 Why?
Troponin
2
2007
44
0.030
 Why?
Physicians
1
2004
772
0.030
 Why?
Immunoglobulin M
2
2009
251
0.030
 Why?
Creatinine
1
2017
425
0.030
 Why?
Myalgia
1
2015
15
0.030
 Why?
Angioplasty, Balloon, Coronary
1
1996
146
0.030
 Why?
Social Class
1
2016
205
0.030
 Why?
Thrombolytic Therapy
1
1996
117
0.030
 Why?
Receptors, LDL
1
2015
38
0.030
 Why?
Chemotherapy, Adjuvant
1
1996
332
0.030
 Why?
Liver
1
2022
1681
0.030
 Why?
Myositis
1
2015
44
0.030
 Why?
Carotid Intima-Media Thickness
1
2015
65
0.030
 Why?
Lidocaine
1
1994
41
0.030
 Why?
Hypertrophy, Left Ventricular
1
1995
103
0.030
 Why?
Stroke Volume
1
1997
510
0.030
 Why?
Electric Stimulation
1
1995
261
0.030
 Why?
Adenosine
2
1994
204
0.030
 Why?
Fat Emulsions, Intravenous
1
1994
30
0.030
 Why?
ATP-Binding Cassette Transporters
1
2015
123
0.030
 Why?
Osmolar Concentration
1
1994
174
0.030
 Why?
Analysis of Variance
1
2017
1229
0.030
 Why?
Glomerular Filtration Rate
1
2017
604
0.030
 Why?
Adenosine Diphosphate
1
1994
81
0.030
 Why?
Mitochondria, Heart
1
1994
73
0.030
 Why?
Hyperglycemia
1
2017
293
0.030
 Why?
NAD
1
1994
64
0.030
 Why?
Glycine
1
1994
153
0.030
 Why?
Patient Outcome Assessment
1
2014
122
0.030
 Why?
Perioperative Period
1
2013
49
0.030
 Why?
Oxidative Phosphorylation
1
1994
156
0.030
 Why?
Vascular Cell Adhesion Molecule-1
1
2013
35
0.030
 Why?
Immunoglobulin G
2
2009
776
0.030
 Why?
Heparin
1
1994
222
0.030
 Why?
Weight Gain
1
2016
451
0.030
 Why?
Smoking
1
2000
1392
0.030
 Why?
Socioeconomic Factors
1
2016
1081
0.030
 Why?
South Africa
1
2013
161
0.030
 Why?
Actinin
1
2012
13
0.030
 Why?
Patient Selection
1
1996
646
0.030
 Why?
Perfusion
1
1992
151
0.030
 Why?
Mathematics
1
1992
101
0.020
 Why?
Cardiac Output, Low
1
1992
64
0.020
 Why?
Anticoagulants
1
1996
546
0.020
 Why?
Electrophoresis, Polyacrylamide Gel
1
2012
317
0.020
 Why?
Reperfusion
1
1991
37
0.020
 Why?
Biopsy
1
1995
1046
0.020
 Why?
Disease-Free Survival
1
2013
617
0.020
 Why?
Patient Discharge
1
2017
767
0.020
 Why?
Dogs
2
1982
340
0.020
 Why?
Constriction
1
1990
45
0.020
 Why?
Alleles
1
2013
792
0.020
 Why?
Hypoglycemia
1
2015
385
0.020
 Why?
Equipment Design
1
1992
513
0.020
 Why?
Cognition Disorders
1
2014
475
0.020
 Why?
Mice
2
2016
14927
0.020
 Why?
Autoantibodies
2
2009
1354
0.020
 Why?
Polymorphism, Single Nucleotide
1
2016
1901
0.020
 Why?
Fibrin Fibrinogen Degradation Products
1
2009
81
0.020
 Why?
Thromboembolism
1
2009
93
0.020
 Why?
Databases, Factual
1
2013
1132
0.020
 Why?
Densitometry
1
2007
29
0.020
 Why?
Spectrin
1
2007
13
0.020
 Why?
Desmin
1
2007
31
0.020
 Why?
Sarcoplasmic Reticulum Calcium-Transporting ATPases
1
2007
36
0.020
 Why?
Kidney
1
2014
1186
0.020
 Why?
Heart Diseases
1
1990
330
0.020
 Why?
Calcium-Binding Proteins
1
2007
205
0.020
 Why?
ROC Curve
1
2007
447
0.020
 Why?
Fatal Outcome
1
2006
285
0.020
 Why?
Protein Processing, Post-Translational
1
2007
399
0.020
 Why?
Apolipoprotein B-100
1
2004
8
0.020
 Why?
Angina Pectoris
1
2004
63
0.010
 Why?
Solubility
1
2004
224
0.010
 Why?
Health Care Surveys
1
2004
538
0.010
 Why?
Immunohistochemistry
1
2006
1634
0.010
 Why?
Odds Ratio
1
2004
957
0.010
 Why?
Echocardiography
2
1997
557
0.010
 Why?
Electrophysiology
1
1982
201
0.010
 Why?
Young Adult
1
2016
10498
0.010
 Why?
Vascular Surgical Procedures
1
2004
259
0.010
 Why?
Adolescent
2
2016
17862
0.010
 Why?
Vascular Resistance
1
1982
337
0.010
 Why?
Thorax
1
1997
41
0.010
 Why?
Phosphorus Isotopes
1
1995
8
0.010
 Why?
Infusions, Parenteral
1
1994
37
0.010
 Why?
Basal Metabolism
1
1994
46
0.010
 Why?
Cardiac Pacing, Artificial
1
1995
79
0.010
 Why?
Substrate Specificity
1
1995
355
0.010
 Why?
Glycolysis
1
1995
227
0.010
 Why?
Lung
1
2006
3595
0.010
 Why?
Rats, Sprague-Dawley
1
1997
2212
0.010
 Why?
Rats
1
1997
4973
0.010
 Why?
Cardiomegaly
1
1990
159
0.010
 Why?
Hydrogen-Ion Concentration
1
1990
512
0.000
 Why?
Cardiomyopathy, Dilated
1
1990
351
0.000
 Why?
Magnetic Resonance Imaging
1
1990
3116
0.000
 Why?
Schwartz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (478) concept(s)
_
Co-Authors Expand Description
See all (16) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)